Evidence map›Paper›PMID 26678083›Full record

ArticleNature protocols2016

Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics.

Majid Ebrahimi Warkiani, Bee Luan Khoo, Lidan Wu, Andy Kah Ping Tay, Ali Asgar S Bhagat, Jongyoon Han, Chwee Teck Lim

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Nature protocols, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04239105 (Detection and Analysis of Circulating Tumor Cells), which is not on this map. Cited by 204 papers.

0numbers the graph read from it
0cells of the map it votes in
204citing papers in PubMed
25.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04239105 unknown statusnot on this mapstarted 2020, after this paper: background citation

Detection and Analysis of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Using a Novel Microfluidic and Raman Spectrum Device

TypeobservationalSponsorXijing HospitalRan2020 to 2022Enrolled120ConditionsBreast Neoplasms, Circulating Tumor CellsArmsMicrofluidic and Raman spectrum
3 · Its place in the literature

Who cites it

204 citing papers in PubMed, 547 citations in OpenAlex.

  1. Article
  2. Article
  3. Separation of Human P63Analytical chemistry · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Precision Oncology Framework Using Circulating Tumor Cells.International journal of molecular sciences · 2025
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Label-Free Microfluidic Apheresis of Circulating Tumor Cell Clusters.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  20. Review

144 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Majid Ebrahimi WarkianiSchool of Mechanical and Manufacturing Engineering, Australian Center for NanoMedicine, University of New South Wales, Sydney, New South Wales, Australia.
Bee Luan KhooBioSystems and Micromechanics (BioSyM), Singapore-MIT Alliance for Research and Technology (SMART) Centre, Singapore, Singapore.
Lidan WuDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Andy Kah Ping TayBioSystems and Micromechanics (BioSyM), Singapore-MIT Alliance for Research and Technology (SMART) Centre, Singapore, Singapore.
Ali Asgar S BhagatClearbridge BioMedics Pte Ltd, Singapore, Singapore.
Jongyoon HanBioSystems and Micromechanics (BioSyM), Singapore-MIT Alliance for Research and Technology (SMART) Centre, Singapore, Singapore.
Chwee Teck LimBioSystems and Micromechanics (BioSyM), Singapore-MIT Alliance for Research and Technology (SMART) Centre, Singapore, Singapore.
Singapore-MIT Alliance for Research and Technology · SGMassachusetts Institute of Technology · USNational University of Singapore · SGUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating tumor cells (CTCs) are rare cancer cells that are shed from primary or metastatic tumors into the peripheral blood circulation. Phenotypic and genetic characterization of these rare cells can provide important information to guide cancer staging and treatment, and thus further research into their characteristics and properties is an area of considerable interest. In this protocol, we describe detailed procedures for the production and use of a label-free spiral microfluidic device to allow size-based isolation of viable CTCs using hydrodynamic forces that are present in curvilinear microchannels. This spiral system enables us to achieve ≥ 85% recovery of spiked cells across multiple cancer cell lines and 99.99% depletion of white blood cells in whole blood. The described spiral microfluidic devices can be produced at an extremely low cost using standard microfabrication and soft lithography techniques (2-3 d), and they can be operated using two syringe pumps for lysed blood samples (7.5 ml in 12.5 min for a three-layered multiplexed chip). The fast processing time and the ability to collect CTCs from a large patient blood volume allows this technique to be used experimentally in a broad range of potential genomic and transcriptomic applications.

Indexed as

Lab-On-A-Chip DevicesCell DeathCell Line, TumorCell SeparationEquipment DesignHumansMicrospheresNeoplastic Cells, CirculatingTime Factors

Identifiers

PMID26678083
OpenAlexW2207498669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.